$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

$blfs Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000114420416118414 Filed on August 11, 2016

Income Statement

Concept	2016 Q3	2016 Q2	2015 Q4
Revenue	$2.135M	$1.990M	$1.820M
YoY Change	30.84%	32.95%	8.98%
Cost Of Revenue	$920.9K	$872.8K	$680.0K
YoY Change	39.84%	28.72%	1.49%
Gross Profit	$1.214M	$1.117M	$1.140M
YoY Change	24.75%	36.46%	14.0%
Gross Profit Margin	56.87%	56.14%	62.64%
Selling, General & Admin	$1.855M	$2.112M	$2.120M
YoY Change	-4.38%	26.23%	29.27%
% of Gross Profit	152.79%	189.05%	185.96%
Research & Development	$496.9K	$599.0K	$430.0K
YoY Change	50.78%	98.79%	19.44%
% of Gross Profit	40.92%	53.62%	37.72%
Depreciation & Amortization	$100.0K	$90.00K	$80.00K
YoY Change	11.11%	0.0%	14.29%
% of Gross Profit	8.24%	8.06%	7.02%
Operating Expenses	$2.352M	$2.711M	$2.540M
YoY Change	3.63%	37.3%	27.0%
Operating Profit	-$1.138M	-$1.594M	-$1.400M
YoY Change	-12.23%	37.89%	40.0%
Interest Expense	$33.33K	-$10.00K	$0.00
YoY Change		-200.0%
% of Operating Profit
Other Income/Expense, Net	-$128.1K	-$125.8K	$0.00
YoY Change	-2809.14%	-2395.2%	-100.0%
Pretax Income	-$1.270M	-$1.720M	-$1.400M
YoY Change	-1.55%	49.57%	40.0%
Income Tax
% Of Pretax Income
Net Earnings	-$969.0K	-$1.356M	-$1.120M
YoY Change	-9.33%	36.37%	23.08%
Net Earnings / Revenue	-45.38%	-68.15%	-61.54%
Basic Earnings Per Share
Diluted Earnings Per Share	-$76.38K	-$108.2K	-$90.98K
COMMON SHARES
Basic Shares Outstanding	12.88M shares	12.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q3	2016 Q2	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.400M	$1.300M	$3.800M
YoY Change	-73.58%	-81.16%	-61.62%
Cash & Equivalents	$1.369M	$1.318M	$2.173M
Short-Term Investments	$0.00	$0.00	$1.700M
Other Short-Term Assets	$400.0K	$400.0K	$400.0K
YoY Change	-20.0%	33.33%	0.0%
Inventory	$1.900M	$1.911M	$1.835M
Prepaid Expenses
Receivables	$1.300M	$1.284M	$929.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.000M	$4.916M	$6.973M
YoY Change	-39.76%	-47.14%	-42.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.300M	$1.362M	$1.446M
YoY Change	-13.33%	-14.88%	-14.92%
Goodwill
YoY Change
Intangibles		$2.215M	$2.215M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$0.00
YoY Change
Total Long-Term Assets	$5.800M	$5.635M	$5.397M
YoY Change	18.37%	22.5%	38.38%
TOTAL ASSETS
Total Short-Term Assets	$5.000M	$4.916M	$6.973M
Total Long-Term Assets	$5.800M	$5.635M	$5.397M
Total Assets	$10.80M	$10.55M	$12.37M
YoY Change	-18.18%	-24.1%	-23.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.100M	$864.5K	$1.029M
YoY Change	10.0%	44.08%	105.87%
Accrued Expenses	$500.0K	$80.04K	$146.4K
YoY Change	0.0%	-79.99%	-79.08%
Deferred Revenue
YoY Change
Short-Term Debt	$1.800M	$700.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.500M	$2.264M	$1.726M
YoY Change	118.75%	88.63%	32.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$700.0K	$700.0K	$800.0K
YoY Change	-12.5%	-12.5%	-11.11%
Total Long-Term Liabilities	$700.0K	$700.0K	$800.0K
YoY Change	-12.5%	-12.5%	-11.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.500M	$2.264M	$1.726M
Total Long-Term Liabilities	$700.0K	$700.0K	$800.0K
Total Liabilities	$4.600M	$3.004M	$2.510M
YoY Change	12.2%	-20.94%	-41.62%
SHAREHOLDERS EQUITY
Retained Earnings		-$66.91M	-$64.33M
YoY Change
Common Stock		$73.73M	$72.84M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.200M	$6.822M	$8.508M
YoY Change
Total Liabilities & Shareholders Equity	$10.80M	$10.55M	$12.37M
YoY Change	-18.18%	-24.1%	-23.17%

Cashflow Statement

Concept	2016 Q3	2016 Q2	2015 Q4
OPERATING ACTIVITIES
Net Income	-$969.0K	-$1.356M	-$1.120M
YoY Change	-9.33%	36.37%	23.08%
Depreciation, Depletion And Amortization	$100.0K	$90.00K	$80.00K
YoY Change	11.11%	0.0%	14.29%
Cash From Operating Activities	-$880.0K	-$1.190M	-$1.270M
YoY Change	-24.79%	-2.46%	84.06%
INVESTING ACTIVITIES
Capital Expenditures	-$200.0K	-$210.0K	-$420.0K
YoY Change	-53.49%	-60.38%	23.53%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$1.240M
YoY Change	-100.0%	-100.0%	313.33%
Cash From Investing Activities	-$200.0K	-$210.0K	$820.0K
YoY Change	-48.72%	-110.05%	-1740.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.130M	1.050M	270.0K
YoY Change	5550.0%	1650.0%
NET CHANGE
Cash From Operating Activities	-880.0K	-1.190M	-1.270M
Cash From Investing Activities	-200.0K	-210.0K	820.0K
Cash From Financing Activities	1.130M	1.050M	270.0K
Net Change In Cash	50.00K	-350.0K	-180.0K
YoY Change	-103.25%	-137.63%	-75.68%
FREE CASH FLOW
Cash From Operating Activities	-$880.0K	-$1.190M	-$1.270M
Capital Expenditures	-$200.0K	-$210.0K	-$420.0K
Free Cash Flow	-$680.0K	-$980.0K	-$850.0K
YoY Change	-8.11%	42.03%	142.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	929289	USD
CY2016Q2	blfs	Deferred Rent Long Term DeferredRentLongTerm	740888	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1446399	USD
CY2016Q2	us-gaap	Short Term Investments ShortTermInvestments	0	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1643840	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1296210	USD
	us-gaap	Gross Profit GrossProfit	2198165	USD
	us-gaap	Gross Profit GrossProfit	1701271	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1103270	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	623499	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1583106	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1142745	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2598110	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2251406	USD
	us-gaap	Operating Expenses OperatingExpenses	5284486	USD
	us-gaap	Operating Expenses OperatingExpenses	4017650	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3086321	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2316379	USD
	us-gaap	Other Income OtherIncome	2364	USD
	us-gaap	Other Income OtherIncome	13719	USD
	us-gaap	Profit Loss ProfitLoss	-3210225	USD
	us-gaap	Profit Loss ProfitLoss	-2302660	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-627314	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-276799	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2582911	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2025861	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12512949	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12122667	shares
CY2016Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	872835	USD
CY2015Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	130216	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2173258	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	523694	USD
CY2016Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	130216	USD
CY2016Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	36166	USD
CY2015Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1698735	USD
CY2015Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	36166	USD
CY2016Q2	us-gaap	Assets Assets	10550454	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1029373	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	80037	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2263541	USD
CY2015Q4	blfs	Deferred Rent Long Term DeferredRentLongTerm	784458	USD
CY2016Q2	us-gaap	Liabilities Liabilities	3004429	USD
CY2015Q4	us-gaap	Liabilities Liabilities	2510251	USD
CY2016Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1029600	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	12447	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	72823398	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2867678	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66909834	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1361859	USD
CY2016Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	2021489	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1318469	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2215385	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2215385	USD
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	1651341	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1284015	USD
CY2015Q4	us-gaap	Assets Assets	12369622	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	864452	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	1910729	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	1834635	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146438	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	402342	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	419766	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	384414	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	4915555	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	6972937	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1725793	USD
CY2016Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1284491	USD
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1284491	USD
CY2016Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	652941	USD
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	557666	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	12607	USD
CY2015Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1025521	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	73719666	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2967032	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	0	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	-451	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1605173	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1421279	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	1350900	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	723586	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7546025	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9859371	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12369622	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	6822439	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	8508471	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10550454	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64326923	USD
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	422326	USD
CY2015Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	678111	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	1117153	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	818648	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	599031	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-1719712	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	-1150395	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-363629	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-156016	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2297602	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2582460	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	301334	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	849193	USD
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	642490	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1262818	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1030701	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	2711042	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	1974525	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1593889	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1155877	USD
CY2016Q2	us-gaap	Other Income OtherIncome	445	USD
CY2015Q2	us-gaap	Other Income OtherIncome	5482	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-1356083	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-994379	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12568041	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12144776	shares
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	451	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5058	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-451	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-5058	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-627314	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-276799	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3209774	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2020803	USD
CY2016Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2015Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-441	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	441	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-363629	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-156016	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1719712	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1150836	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1356083	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-994820	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	451	USD
CY2016Q2	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	1264989	USD
CY2016Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	53480	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1318469	USD
CY2016Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	1318469	USD
CY2015Q4	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	440809	USD
CY2015Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	1732449	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2173258	USD
CY2015Q4	us-gaap	Financial Instruments Owned Corporate Debt At Fair Value FinancialInstrumentsOwnedCorporateDebtAtFairValue	1401453	USD
CY2015Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	249888	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1651341	USD
CY2015Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	3824599	USD
CY2016Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	504652	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	299952	USD
CY2016Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.40
CY2016Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	344946	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	666124	USD
CY2016Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1061131	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	868559	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	423326	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	41413	USD
CY2016Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7745997	USD
	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	59700	USD
CY2016Q2	us-gaap	Area Of Land AreaOfLand	30000	acre
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	45667	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0145	pure
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.75	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0152	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.75	pure
	blfs	Estimated Forfeiture Rate EstimatedForfeitureRate	0.081	pure
	blfs	Estimated Forfeiture Rate EstimatedForfeitureRate	0.070	pure
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2007687	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M6D
	us-gaap	Share Based Compensation ShareBasedCompensation	402763	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	158371	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	256235	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	124862	USD
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2021-07-31
CY2014Q3	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	2400000	USD
CY2016Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	2000000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	BIOLIFE SOLUTIONS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0000834365
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	BLFS
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12883246	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>Concentrations of credit risk and business risk</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In the three and six months ended June 30, 2016, we derived approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 12</font>% of our product revenue from one customer. In the three and six months ended June 30, 2015, we derived approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of our product revenue from one customer. No other customer accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10</font></font></font></font>% of revenue in the three and six months ended June 30, 2016 or 2015. At June 30, 2016, three customers accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 41</font>% of total gross accounts receivable. At December 31, 2015, three customers accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 53</font>% of total gross accounts receivable.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Revenue from customers located in foreign countries represented <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 17</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>% of total revenue during the three and six months ended June 30, 2016, <font style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> respectively,</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21</font>% during the three and six months ended June 30, 2015, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	8333	USD
CY2016Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	656809	USD
CY2015Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12607055	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12607055	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12448391	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12448391	shares
CY2016Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	343191	USD
CY2016Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	8333	USD
CY2015Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	USD
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	8333	USD
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	USD
CY2016Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	31199	USD
CY2015Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	31199	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2016Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	86736	USD
CY2015Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	86736	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-125823	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5482	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-123904	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13719	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2997481	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.24
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1989988	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1496759	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3842005	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.25
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.75
CY2016Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	23633	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	122351	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0177	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0177	pure
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0	pure
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.05	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.05	pure
CY2015Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7195997	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.60
	us-gaap	Lessee Leasing Arrangements Operating Leases Renewal Term LesseeLeasingArrangementsOperatingLeasesRenewalTerm	P5Y
CY2016Q2	blfs	Estimated Forfeiture Rate EstimatedForfeitureRate	0.081	pure
CY2015Q2	blfs	Estimated Forfeiture Rate EstimatedForfeitureRate	0.070	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.75
	blfs	Outstanding Warrants Expiration Dates OutstandingWarrantsExpirationDates	The outstanding warrants have expiration dates between August 2016 and May 2021.
CY2016Q2	blfs	Leasehold Improvements Gross1 LeaseholdImprovementsGross1	1124790	USD
CY2015Q4	blfs	Leasehold Improvements Gross1 LeaseholdImprovementsGross1	1124790	USD
CY2016Q2	blfs	Leasehold Improvements LeaseholdImprovements	685761	USD
CY2015Q4	blfs	Leasehold Improvements LeaseholdImprovements	749260	USD
CY2016Q2	us-gaap	Deferred Rent Credit DeferredRentCredit	871104	USD
CY2015Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	914674	USD
CY2016Q2	blfs	Less Accumulated Amortization LessAccumulatedAmortization	439029	USD
CY2015Q4	blfs	Less Accumulated Amortization LessAccumulatedAmortization	375530	USD
CY2016Q2	blfs	Straight Line Rent Adjustment StraightLineRentAdjustment	185343	USD
CY2015Q4	blfs	Straight Line Rent Adjustment StraightLineRentAdjustment	165414	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	374390	USD
	us-gaap	Depreciation Depreciation	183893	USD
	us-gaap	Depreciation Depreciation	168727	USD
	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	-63499	USD
	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	-63500	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1792	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-65485	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	354726	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-92236	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	76094	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	356033	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	50151	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-47762	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	207369	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-99771	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	37527	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-267229	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	8333	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	blfs	Deferred Rent DeferredRent	19929	USD
	blfs	Deferred Rent DeferredRent	21651	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2775154	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2534961	USD
	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	1650000	USD
	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	4725000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	342872	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	695044	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	497480	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	99353	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	72009	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	855603	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	3812639	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	86736	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1064762	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	79969	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-854789	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1357647	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2538758	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3896405	USD
	blfs	Payments To Develop Software Not Paid PaymentsToDevelopSoftwareNotPaid	42760	USD
	blfs	Payments To Develop Software Not Paid PaymentsToDevelopSoftwareNotPaid	265380	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1000000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	151498	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	79969	USD

Files In Submission

Name	View Source	Status
0001144204-16-118414-index-headers.html	Edgar Link	pending
0001144204-16-118414-index.html	Edgar Link	pending
0001144204-16-118414.txt	Edgar Link	pending
0001144204-16-118414-xbrl.zip	Edgar Link	pending
blfs-20160630.xml	Edgar Link	completed
blfs-20160630.xsd	Edgar Link	pending
blfs-20160630_cal.xml	Edgar Link	unprocessable
blfs-20160630_def.xml	Edgar Link	unprocessable
blfs-20160630_lab.xml	Edgar Link	unprocessable
blfs-20160630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tlogo.jpg	Edgar Link	pending
v445671_10q.htm	Edgar Link	pending
v445671_ex10-1.htm	Edgar Link	pending
v445671_ex31-1.htm	Edgar Link	pending
v445671_ex31-2.htm	Edgar Link	pending
v445671_ex32-1.htm	Edgar Link	pending
v445671_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

2016 Q3 Form 10-Q Financial Statement

#000114420416118414 Filed on August 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS BIOLIFE SOLUTIONS INC Stock $blfs

2016 Q3 Form 10-Q Financial Statement

#000114420416118414 Filed on August 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs